Jun O. Liu

19.4k total citations · 3 hit papers
210 papers, 14.2k citations indexed

About

Jun O. Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jun O. Liu has authored 210 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Molecular Biology, 65 papers in Oncology and 34 papers in Cancer Research. Recurrent topics in Jun O. Liu's work include Signaling Pathways in Disease (48 papers), Peptidase Inhibition and Analysis (42 papers) and Ubiquitin and proteasome pathways (19 papers). Jun O. Liu is often cited by papers focused on Signaling Pathways in Disease (48 papers), Peptidase Inhibition and Analysis (42 papers) and Ubiquitin and proteasome pathways (19 papers). Jun O. Liu collaborates with scholars based in United States, China and South Korea. Jun O. Liu's co-authors include Joong Sup Shim, Yongjun Dang, Shridhar Bhat, Curtis R. Chong, Hong‐Duk Youn, Daniel Romo, Edward Licitra, Bo Huang, Qian Chen and Yi Liu‐Chittenden and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jun O. Liu

207 papers receiving 14.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

2012 1.1k citations Joong Sup Shim, Jun O. Liu et al. profile →
Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin

2010 717 citations Jun O. Liu et al. profile →
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth

2008 520 citations Yunzhao R. Ren, Jun O. Liu et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Jun O. Liu

Since Specialization

Citations

This map shows the geographic impact of Jun O. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun O. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun O. Liu more than expected).

Fields of papers citing papers by Jun O. Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun O. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun O. Liu. The network helps show where Jun O. Liu may publish in the future.

Co-authorship network of co-authors of Jun O. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jun O. Liu. A scholar is included among the top collaborators of Jun O. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun O. Liu. Jun O. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Zinc finger protein Zfp335 is required for T cell homeostatic proliferation through regulating Lmnb1 2025 ·Cell & Bioscience ·Biao Yang, Wenhua Li, Xin Wang, Ning Yuan, Yang Gao, (unknown), Jun O. Liu, (unknown), Haiyan Liu, (unknown), Peng R. Chen, Xiaofeng Yang, Lei Lei, Xiaobo Zhou, Hui Zhang, Baojun Zhang	0
2	When artificial intelligence (AI) meets organoids and organs-on-chips (OoCs): Game-changer for drug discovery and development? 2025 ·(unknown), Shangsi Chen, Jun O. Liu, (unknown), Zhengyin Yan, Chenzhong Li, Xiangxiang Zeng, Rocky S. Tuan, Zhong Li	10
3	Zinc oxide nanoparticles cause hepatotoxicity in rare minnow (Gobiocypris rarus) via ROS-mediated oxidative stress and apoptosis activation and inhibition of lipid peroxidation 2024 ·Aquaculture Reports ·(unknown), (unknown), Jiahuan Wang, Jinming Wu, (unknown), (unknown), Jun O. Liu	4
4	Insights into the structure–activity relationship of the anticancer compound ZJ-101: A role played by the amide moiety 2024 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Shan Qian, Sarah A. Head, (unknown), Jun O. Liu, Zhendong Jin	2
5	Targeting RPA promotes autophagic flux and the antitumor response to radiation in nasopharyngeal carcinoma 2023 ·Journal of Translational Medicine ·Yanchun Feng, Yingming Jiang, Jun O. Liu, (unknown), (unknown), Junxiong Chen, Jingdan Zhang, Yu Tian, Xiangling Yang, Huanliang Liu	5
6	Synthesis and biological evaluation of biotinylated ZJ-101 2023 ·Bioorganic & Medicinal Chemistry Letters ·Shan Qian, Sarah A. Head, (unknown), Jun O. Liu, Zhendong Jin	1
7	Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial 2020 ·Cancer Prevention Research ·Lauren M. Hurwitz, İbrahim Kulaç, Berrak Gümüşkaya, Javier Baena-Del Valle, (unknown), Fan Pan, Jun O. Liu, Michael Marrone, Kathryn B. Arnold, Phyllis J. Goodman, Catherine M. Tangen, M. Scott Lucia, Ian M. Thompson, Charles G. Drake, William B. Isaacs, William G. Nelson, Angelo M. De Marzo, Elizabeth A. Platz	7
8	Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors 2020 ·ACS Medicinal Chemistry Letters ·Yingjun Li, Kalyan Kumar Pasunooti, Hanjing Peng, (unknown), Wei Shi, Wukun Liu, Zhiqiang Cheng, Sarah A. Head, Jun O. Liu	4
9	Pharmacophore-Directed Retrosynthesis Applied to Rameswaralide: Synthesis and Bioactivity of Sinularia Natural Product Tricyclic Cores 2019 ·Organic Letters ·(unknown), (unknown), (unknown), Jun O. Liu, Daniel Romo	22
10	Evolved resistance to partial GAPDH inhibition results in loss of the Warburg effect and in a different state of glycolysis 2019 ·Journal of Biological Chemistry ·Maria V. Liberti, Annamarie E. Allen, Vijyendra Ramesh, Ziwei Dai, Katherine R. Singleton, Zufeng Guo, Jun O. Liu, Kris C. Wood, Jason W. Locasale	16
11	Divergence of Antiangiogenic Activity and Hepatotoxicity of Different Stereoisomers of Itraconazole 2016 ·Clinical Cancer Research ·Joong Sup Shim, (unknown), Namandjé N. Bumpus, Sarah A. Head, Kalyan Kumar Pasunooti, Eun Ju Yang, (unknown), Wei Shi, Jun O. Liu	13
12	Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Rong Chen, Yuling Chen, William Plunkett, Xin Cheng, (unknown), Earl F. Albone, Jun O. Liu, Daniel Romo	23
13	Itraconazole Inhibits Angiogenesis and Tumor Growth in Non–Small Cell Lung Cancer 2011 ·Cancer Research ·Blake T. Aftab, Irina Dobromilskaya, Jun O. Liu, Charles M. Rudin	133
14	A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment 2011 ·Cancer Discovery ·Elizabeth A. Platz, Srinivasan Yegnasubramanian, Jun O. Liu, Curtis R. Chong, Joong Sup Shim, Stacey A. Kenfield, Meir J. Stampfer, Walter C. Willett, Edward L. Giovannucci, William G. Nelson	141
15	High-Throughput Screen Identifies Novel Inhibitors of Cancer Biomarker α-Methylacyl Coenzyme A Racemase (AMACR/P504S) 2011 ·Molecular Cancer Therapeutics ·Brice A. P. Wilson, Haofan Wang, Benjamin A. Nacev, Ronnie C. Mease, Jun O. Liu, Martin G. Pomper, William B. Isaacs	44
16	Eos Mediates Foxp3-Dependent Gene Silencing in CD4 ⁺ Regulatory T Cells 2009 ·Science ·Fan Pan, Hong Yu, Eric V. Dang, Joseph Barbi, Xiaoyu Pan, Joseph F. Grosso, (unknown), Sudarshana M. Sharma, (unknown), Derese Getnet, Charles G. Drake, Jun O. Liu, Michael C. Ostrowski, Drew M. Pardoll	245
17	Identification of Inhibitors of ABCG2 by a Bioluminescence Imaging–Based High-Throughput Assay 2009 ·Cancer Research ·Yimao Zhang, Youngjoo Byun, Yunzhao R. Ren, Jun O. Liu, John Laterra, Martin G. Pomper	34
18	Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization 2007 ·Journal of Biological Chemistry ·Ye V. Liu, Maimon E. Hubbi, Fan Pan, Karin R. McDonald, Malini Mansharamani, Robert N. Cole, Jun O. Liu, Gregg L. Semenza	127
19	Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity 2006 ·Proceedings of the National Academy of Sciences ·Xiaochun Chen, Curtis R. Chong, Lirong Shi, Tadashi Yoshimoto, David Sullivan, Jun O. Liu	82
20	Crystal structure of calcineurin–cyclophilin–cyclosporin shows common but distinct recognition of immunophilin–drug complexes 2002 ·Proceedings of the National Academy of Sciences ·Qing Huai, Hwa-Young Kim, Yudong Liu, Yingdong Zhao, (unknown), Jun O. Liu, Hengming Ke	214

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact